Literature DB >> 24889573

Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges.

Gunar Günther1.   

Abstract

Multidrug-resistant and extensively drug-resistant tuberculosis are recent global health issues, which makes tuberculosis - after the success of short course treatment during the second half of the last century - a major health challenge. Globalisation, health inequalities, competing economic interests and political instability contribute substantially to the spread of drug-resistant strains, which are associated with high rates of morbidity and mortality. Issues such as increasing transmission of drug-resistant strains, poor diagnostic coverage and a lengthy, toxic treatment need to be overcome by innovative approaches to tuberculosis control, prevention, diagnostics and treatment. This review addresses recent developments and future concepts.
© 2014 Royal College of Physicians.

Entities:  

Keywords:  Drug-resistant; anti-tuberculosis drugs; resistance testing; tuberculosis; tuberculosis control

Mesh:

Substances:

Year:  2014        PMID: 24889573      PMCID: PMC4952541          DOI: 10.7861/clinmedicine.14-3-279

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  33 in total

Review 1.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Authors:  Denise Kirschner; Elsje Pienaar; Simeone Marino; Jennifer J Linderman
Journal:  Curr Opin Syst Biol       Date:  2017-05-22

3.  Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.

Authors:  Zhaojing Zong; Wei Jing; Jin Shi; Shu'an Wen; Tingting Zhang; Fengmin Huo; Yuanyuan Shang; Qian Liang; Hairong Huang; Yu Pang
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Fragment-based exploration of binding site flexibility in Mycobacterium tuberculosis BioA.

Authors:  Ran Dai; Todd W Geders; Feng Liu; Sae Woong Park; Dirk Schnappinger; Courtney C Aldrich; Barry C Finzel
Journal:  J Med Chem       Date:  2015-06-24       Impact factor: 7.446

5.  BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination.

Authors:  Fan Chen; Qinying Yan; Yang Yu; Mei X Wu
Journal:  J Control Release       Date:  2017-04-05       Impact factor: 9.776

6.  Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).

Authors:  Pooja V Hegde; Michael D Howe; Matthew D Zimmerman; Helena I M Boshoff; Sachin Sharma; Brianna Remache; Ziyi Jia; Yan Pan; Anthony D Baughn; Veronique Dartois; Courtney C Aldrich
Journal:  Eur J Med Chem       Date:  2022-02-19       Impact factor: 6.514

7.  Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT.

Authors:  Barbara Molina-Moya; Michel Kiréopori Gomgnimbou; Carmen Lafoz; Alicia Lacoma; Cristina Prat; Guislaine Refrégier; Sofia Samper; Jose Dominguez; Christophe Sola
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

8.  A 10-Year Comparative Analysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacterium tuberculosis in China Is Associated with the Transmission of Strains Harboring Compensatory Mutations.

Authors:  Fengmin Huo; Jingjing Luo; Jin Shi; Zhaojing Zong; Wei Jing; Wenzhu Dong; Lingling Dong; Yifeng Ma; Qian Liang; Yuanyuan Shang; Hairong Huang; Yu Pang
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

9.  Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.

Authors:  Karla D Passalacqua; Marie-Eve Charbonneau; Nicholas J Donato; Hollis D Showalter; Duxin Sun; Bo Wen; Miao He; Hanshi Sun; Mary X D O'Riordan; Christiane E Wobus
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches.

Authors:  Qinying Yan; Houming Liu; Zhigang Cheng; Yun Xue; Zhide Cheng; Xuyong Dai; Wanshui Shan; Fan Chen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.